Skip to main content
Fig. 5 | BMC Pregnancy and Childbirth

Fig. 5

From: Soluble urokinase plasminogen activator receptor in vaginally collected amniotic fluid predicting fetal inflammatory response syndrome: a prospective cohort study

Fig. 5

SuPAR concentrations in FIRS groups according to the presence or absence of histological chorioamnionitis: FIRS with histological chorioamnionitis, median, 38.98 ng/mL, IQR, 28.25–89.85, vs. FIRS without histological chorioamnionitis, median, 15.10, IQR, 11.87–19.21, vs. non-FIRS with histological chorioamnionitis, median, 22.73 ng/mL, IQR, 11.30–37.77, vs. non-FIRS no histological chorioamnionitis, median, 20.46 ng/mL, IQR, 13.17–35.97; Kruskal, P < 0.001. suPAR, soluble urokinase plasminogen activator receptor; FIRS, fetal inflammatory response syndrome; IQR, interquartile range.; HCA, histological chorioamnionitis; IQR, interquartile range

Back to article page